Vertex Pharmaceuticals Inc (VRTX) operating KPIs
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$558.88+18.88 (+3.50%)
Close on Oct 30, 2026Market cap $141.65BP/E 32.5Yield –
KPIs
Operating metrics that drive Vertex Pharmaceuticals's business
Coming soon
This tab will track the numbers specific to Vertex Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.